<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37128534</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>COVID-19: Post-recovery Manifestations.</ArticleTitle><Pagination><StartPage>e36886</StartPage><MedlinePgn>e36886</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e36886</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.36886</ELocationID><Abstract><AbstractText>Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus. Methodology We distributed a web-based survey among patients diagnosed with COVID-19&#xa0;across the world and collected 190 responses regarding their demographics, histories, COVID-19 infection courses, and common symptoms. Results We found that about 85.3% of the patients experienced some form of symptom following recovery from the infection. Among the reported symptoms, 59% of patients experienced fatigue or lethargy, 48.9% reported decreased stamina, 32.6% reported&#xa0;shortness of breath, 16.8% had a persistent cough, and 23.7% experienced anxiety following recovery from COVID-19. Conclusions Reported symptoms closely resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a deeper biochemical understanding of ME/CFS is required to confirm causation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Shaikh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Safia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research, Southwest Family Medicine Associates, Dallas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddiqi</LastName><ForeName>Zunaira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>General Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukachukwu</LastName><ForeName>Crystal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>General Medicine, University College Hospital, Ibadan, NGA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehkari</LastName><ForeName>Zainab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine, California Institute of Behavioral Neurosciences &amp; Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Approval, PPD Inc, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamurthy</LastName><ForeName>Ketan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical School, Brown University, Providence, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahan</LastName><ForeName>Farhat</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research, St. Michael Hospital Research Laboratory, Ontario, CAN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Amaiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical School, University of Arlington, Arlington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">covid-19 manifestation</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">post-covid-19 recovery symptoms</Keyword><Keyword MajorTopicYN="N">post-covid-19 syndrome</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37128534</ArticleId><ArticleId IdType="pmc">PMC10147564</ArticleId><ArticleId IdType="doi">10.7759/cureus.36886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center. Covid-19 map.  [
Oct;
2021 
];https://coronavirus.jhu.edu/map.html 2021 REFERENCES</Citation></Reference><Reference><Citation>Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Komaroff AL, Bateman L. https://www.frontiersin.org/articles/10.3389/fmed.2020.606824/full. Front Med (Lausanne) 2020;7:606824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Redefining the chronic fatigue syndrome. Ganiats TG. https://www.acpjournals.org/doi/abs/10.7326/M15-0357. Ann Intern Med. 2015;162:653&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">25668185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic fatigue syndrome/myalgic encephalomyelitis is a legitimate disease that needs proper diagnosis and treatment, says IOM; report identifies five symptoms to diagnose disease.  [
Oct;
2021 
]. 2021. https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease https://www.nationalacademies.org/news/2015/02/chronic-fatigue-syndrome-myalgic-encephalomyelitis-is-a-legitimate-disease-that-needs-proper-diagnosis-and-treatment-says-iom-report-identifies-five-symptoms-to-diagnose-disease</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. (2021, September 8. Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)  [
Oct;
2021 
]. 2021. https://www.cdc.gov/me-cfs/index.html https://www.cdc.gov/me-cfs/index.html</Citation></Reference><Reference><Citation>Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Neurosci Biobehav Rev. 2015;57:30&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>The neuroimmune basis of fatigue. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. https://doi.org/10.1016/j.tins.2013.10.003. Trends Neurosci. 2014;37:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889707</ArticleId><ArticleId IdType="pubmed">24239063</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 'long-haulers'? Wood E, Hall KH, Tate W. https://doi.org/10.1016/j.cdtm.2020.11.002. Chronic Dis Transl Med. 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. Grasselli G, Zangrillo A, Zanella A, et al. JAMA. 2020;323:1574&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain. Garcia-Vidal C, C&#xf3;zar-Llist&#xf3; A, Meira F, et al.  https://doi.org/10.1016/j.lanepe.2021.100041. Lancet Reg Health Eur. 2021;3:100041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830193</ArticleId><ArticleId IdType="pubmed">33870249</ArticleId></ArticleIdList></Reference><Reference><Citation>Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China. Yin X, Li Q, Hou S, et al.   https://doi.org/10.1016/j.clinimag.2021.02.034&#xa0;. Clin Imaging. 2021;77:169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901270</ArticleId><ArticleId IdType="pubmed">33691264</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Symptoms of COVID-19.  [
Oct;
2021 
];https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html 2021 4:2021.</Citation></Reference><Reference><Citation>Smoking and COVID-19: what we know so far. Shastri MD, Shukla SD, Chong WC, et al. Respir Med. 2021;176:106237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674982</ArticleId><ArticleId IdType="pubmed">33246296</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Pavli A, Theodoridou M, Maltezou HC. Arch Med Res. 2021;52:575&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Int J Environ Res Public Health. 2021;18:2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and chronic fatigue syndrome: is the worst yet to come? Wostyn P. https://doi.org/10.1016/j.mehy.2020.110469. Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Daher A, Balfanz P, Cornelissen C, et al.  https://doi.org/10.1016/j.rmed.2020.106197. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, et al. Respir Physiol Neurobiol. 2021;288:103644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine. Washington, DC: National Academies Press; 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>